
Heather Hardy’s Adverse Finding
On October 3, 2019, the Voluntary Anti-Doping Association (“VADA”) reported to the World Boxing Council ("WBC") that an “A” sample collected from Heather Hardy on September 12, 2019 in Brooklyn, New York, in connection with a random, out-of-competition collection under the WBC Clean Boxing Program (“WBC CBP”), gave an adverse analytical finding for the presence of Furosemide (the "Finding”).